Drug intelligence / Profile preview

NIKOVIT

Development stage: Unknown
Lead developer: Uniark Healthcare
Modality: Small Molecules
Administration: Oral

Overview

NIKOVIT is a brand of oral nutritional supplements marketed by Uniark Healthcare, an Indian pharmaceutical company. The product line includes various formulations such as NIKOVIT Q10 and NIKOVIT Multivitamins, which are designed to address nutritional deficiencies and support general wellness. These supplements typically contain a combination of vitamins, minerals, and antioxidants like Coenzyme Q10 (ubidecarenone). NIKOVIT is distributed through a Propaganda Cum Distribution (PCD) pharma franchise model, primarily in the Indian market, and is intended to support metabolic processes, cellular energy production, and immune function.

Brand names: NIKOVITNIKOVIT Q10NIKOVIT Multivitamins

Targets

ND1 (Mitochondrial electron transport chain complex I)

Beyond the preview

Go deeper on NIKOVIT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NIKOVIT.

Explore the full profile